Profil
Laurent Higueret currently works at BPIFrance Investissement SAS, as Deputy Director from 2014, Owkin France SASU, as Director, TreeFrog Therapeutics SAS, as Director from 2021, ENYO Pharma SA, as Board observer, and DNA Script SAS, as Observer.
Dr. Higueret also formerly worked at Poxel SA, as Director, Sangamo Therapeutics France SAS, as Director, Voluntis SA, as Director, Biom'Up SA, as Director, Bpifrance SA, as Investment Director, Gensight Biologics SA, as Director, and Dynacure SA, as Observer.
Dr. Higueret received his doctorate degree in 2003 from Université de Bordeaux, graduate degree in 2006 from EM Lyon Business School, and graduate degree in 2005 from KEDGE Business School.
Postes actifs de Laurent Higueret
| Sociétés | Poste | Début |
|---|---|---|
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | - |
Owkin France SASU
Owkin France SASU Medical/Nursing ServicesHealth Services Provides artificial intelligence for predictive medicine | Directeur/Membre du Conseil | - |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Directeur/Membre du Conseil | - |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Directeur/Membre du Conseil | 13/09/2021 |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Private Equity Investor | 01/01/2014 |
Anciens postes connus de Laurent Higueret
| Sociétés | Poste | Fin |
|---|---|---|
| BIOM'UP | Directeur/Membre du Conseil | 02/07/2018 |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Directeur/Membre du Conseil | - |
| VOLUNTIS S.A. | Directeur/Membre du Conseil | - |
Bpifrance SA /Old/
Bpifrance SA /Old/ Financial ConglomeratesFinance Provides investment, financial and support services | Directeur en chef des Investissements | - |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Laurent Higueret
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EM Lyon Business School
EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Finance |
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Voluntis SA
Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Bpifrance SA /Old/
Bpifrance SA /Old/ Financial ConglomeratesFinance Provides investment, financial and support services | Finance |
KEDGE Business School
KEDGE Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Owkin France SASU
Owkin France SASU Medical/Nursing ServicesHealth Services Provides artificial intelligence for predictive medicine | Health Services |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Commercial Services |
















